Strategic partnership leverages Capsida’s next-generation manufacturing capabilities to enable development of KateTx’s gene therapy medicines for muscle and heart diseases THOUSAND OAKS, Calif. and SAN DIEGO, Oct. 3, 2023 /PRNewswire/ — Capsida Biotherapeutics Inc. (“Capsida”) and Kate…
